Top article

FDA approves first cell-culture flu vaccine

FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines), the first cell-culture-derived vaccine, for individuals aged 18 years of age and older. » More

Continuing Education

New CPE Series: November activity available now

Welcome to the third activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The November activity will cover oral antidiabetes agents and noninsulin injectables for diabetes care.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Today's Headlines

Health plan provisions under ACA to be implemented

The Obama administration moved ahead to implement provisions in the healthcare law that would make it illegal for insurance companies to discriminate against people with pre-existing conditions. » More

FDA panel votes against OTC use of OAB agent

An FDA advisory panel voted against making oxybutynin transdermal patch (Oxytrol, Merck and Watson Pharma) available over-the-counter (OTC) for overactive bladder (OAB) in women, Medpage Today reported. » More

Ranbaxy recalls generic Lipitor

More than 40 lots of atorvastatin calcium tablets, the generic version of Pfizer’s Lipitor, are being recalled by Ranbaxy Pharmaceuticals Inc. (RPI) because they may contain glass particles that are estimated to be less than 1 mm in size, according to Ranbaxy's website. » More

TAKE OUR SURVEY

Have you added any new security measures in the last 12 months to protect your pharmacy against crime?

- Yes
- No

Click Here to let us know.

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

• Meningitis outbreak calls for reassessment

• More complications for meningitis patients

• Preterm delivery tocolytic therapy options

• Low back pain difficult to self-manage

Voices

Anticoagulation Update

JP at Large: Just Another Night at the Pharmacy

View from the Zoo: How to solve every problem in pharmacy

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events